New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals
AtomVie Global Radiopharma is the latest company launched by the OICR-supported centre
Excerpt from the Press Release:
The Centre for Probe Development and Commercialization’s (CPDC) newest spinout company has now launched as AtomVie Global Radiopharma Inc.
On August 24, the Hamilton-based radiopharmaceutical company announced it had closed Series A financing with healthcare investment firm Avego Management, which committed at least $40 million.
For the past seven years, the Contract Manufacturing Organization (CMO) business unit, now AtomVie, operated within CPDC as a manufacturer and supplier of finished-dose therapeutic radiopharmaceuticals. Now, the newly announced company will expand its capacity to develop, manufacture and distribute radiopharmaceuticals by building a state-of-the-art facility that can accommodate multiple isotopes and adding a high-standard quality management system and global regulatory support.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?